{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:05Z","timestamp":1740147305101,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"Universit\u00e9 de Lausanne","doi-asserted-by":"publisher","award":["Jeune Chercheur en Recherche Clinique"],"award-info":[{"award-number":["Jeune Chercheur en Recherche Clinique"]}],"id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary treatment of central neurocytomas is surgical resection. Gamma Knife surgery is considered a valuable therapeutic option in case of residual (after subtotal resection) or recurrent central neurocytomas. Here, we focused on the role of F-18\u00a0fluroethyltyrosine as a marker to document tumor progression after initial resection, in the context of an atypical central neurocytoma. We also describe MIB-1\u2019s role in evaluating therapeutic decision-making.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Two patients with central neurocytomas were treated by Gamma Knife surgery in our center. The first case (31-year-old Caucasian male) had atypical central neurocytoma. Four and a half years after surgical resection, magnetic resonance imaging and F-18\u00a0fluroethyltyrosine documented clear progression of residual central neurocytoma, further treated by Gamma Knife surgery (18\u00a0Gy at 50%, target volume 1.4\u00a0cc, and prescription isodose volume 1.8\u00a0cc). The initial post-Gamma Knife surgery clinical course was uneventful, with progressive volumetric reduction of residual tumor up to 4.5\u00a0years, when out-of-field recurrence was suspected and confirmed by local F-18 fluroethyltyrosine hyperactivity. Second single-fraction Gamma Knife surgery was performed (18\u00a0Gy at 50%, target volume 0.49\u00a0cc, prescription isodose volume 0.72\u00a0cc). The second (32-year-old Caucasian female) had previous subtotal resection and typical central neurocytoma. Seven\u00a0years later, she had residual tumor progression. Single-fraction Gamma Knife surgery was performed (16\u00a0Gy at 50% isodose line, target volume 1.7\u00a0cc, and prescription isodose volume 2.5\u00a0cc). Last follow-up showed tumor volume reduction. Follow-up magnetic resonance imaging showed important volumetric reduction of both treated lesions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In atypical central neurocytomas, F-18\u00a0fluroethyltyrosine could be used as postoperative examination to detect small tumor remnants, follow-up evaluation following the Gamma Knife surgery or, in select cases, following surgical resection. The role of MIB-1 is important in therapeutic decision-making, as tumors with MIB-1 exceeding 2% are characterized by more aggressive clinical course. Single-fraction Gamma Knife surgery remains a valuable therapeutic option for postoperative residual atypical central neurocytomas and central neurocytoma recurrences.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03665-4","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T04:29:20Z","timestamp":1669609760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of single fraction Gamma Knife radiosurgery for intraventricular central neurocytomas and the utility of F-18\u00a0fluroethyltyrosine: two case reports"],"prefix":"10.1186","volume":"16","author":[{"given":"Michaela","family":"Dedeciusova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John O.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Schiappacasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Patin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Levivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-1486","authenticated-orcid":false,"given":"Constantin","family":"Tuleasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"issue":"2","key":"3665_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF00690587","volume":"56","author":"J Hassoun","year":"1982","unstructured":"Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G, Pellissier JF, et\u00a0al. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol. 1982;56(2):151\u20136.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3665_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1750-3639.1993.tb00756.x","volume":"3","author":"J Hassoun","year":"1993","unstructured":"Hassoun J, Soylemezoglu F, Gambarelli D, Figarella-Branger D, von Ammon K, Kleihues P. Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol. 1993;3(3):297\u2013306.","journal-title":"Brain Pathol"},{"issue":"4","key":"3665_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1042-3680(03)00064-0","volume":"14","author":"J Lee","year":"2003","unstructured":"Lee J, Chang SM, McDermott MW, Parsa AT. Intraventricular neurocytomas. Neurosurg Clin N Am. 2003;14(4):483\u2013508.","journal-title":"Neurosurg Clin N Am"},{"issue":"4","key":"3665_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/cncr.20032","volume":"100","author":"D Rades","year":"2004","unstructured":"Rades D, Fehlauer F, Schild SE. Treatment of atypical neurocytomas. Cancer. 2004;100(4):814\u20137.","journal-title":"Cancer"},{"issue":"8","key":"3665_CR5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1212\/WNL.59.8.1268","volume":"59","author":"D Rades","year":"2002","unstructured":"Rades D, Fehlauer F. Treatment options for central neurocytoma. Neurology. 2002;59(8):1268\u201370.","journal-title":"Neurology"},{"issue":"4","key":"3665_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ijrobp.2006.10.018","volume":"67","author":"JL Leenstra","year":"2007","unstructured":"Leenstra JL, Rodriguez FJ, Frechette CM, Giannini C, Stafford SL, Pollock BE, et\u00a0al. Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys. 2007;67(4):1145\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3665_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nec.2014.09.008","volume":"26","author":"EA Monaco 3rd","year":"2015","unstructured":"Monaco EA 3rd, Niranjan A, Lunsford LD. The management of central neurocytoma: radiosurgery. Neurosurg Clin N Am. 2015;26(1):37\u201344.","journal-title":"Neurosurg Clin N Am"},{"key":"3665_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.wneu.2016.03.016","volume":"90","author":"K Yamanaka","year":"2016","unstructured":"Yamanaka K, Iwai Y, Shuto T, Kida Y, Sato M, Hayashi M, et\u00a0al. Treatment results of Gamma Knife radiosurgery for central neurocytoma: report of a Japanese multi-institutional cooperative study. World Neurosurg. 2016;90:300\u20135.","journal-title":"World Neurosurg"},{"key":"3665_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000493069","volume":"34","author":"A Nakamura","year":"2019","unstructured":"Nakamura A, Kano H, Niranjan A, Lunsford LD. Radiosurgery for central neurocytoma. Prog Neurol Surg. 2019;34:232\u20137.","journal-title":"Prog Neurol Surg"},{"issue":"10","key":"3665_CR10","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1002\/cncr.23036","volume":"110","author":"CY Kim","year":"2007","unstructured":"Kim CY, Paek SH, Jeong SS, Chung HT, Han JH, Park CK, et\u00a0al. Gamma knife radiosurgery for central neurocytoma: primary and secondary treatment. Cancer. 2007;110(10):2276\u201384.","journal-title":"Cancer"},{"issue":"3","key":"3665_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11060-011-0635-0","volume":"105","author":"A Genc","year":"2011","unstructured":"Genc A, Bozkurt SU, Karabagli P, Seker A, Bayri Y, Konya D, et\u00a0al. Gamma knife radiosurgery for cranial neurocytomas. J Neurooncol. 2011;105(3):647\u201357.","journal-title":"J Neurooncol"},{"issue":"Suppl","key":"3665_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3171\/2012.6.GKS12214","volume":"117","author":"B Karlsson","year":"2012","unstructured":"Karlsson B, Guo WY, Kejia T, Dinesh N, Pan DH, Jokura H, et\u00a0al. Gamma Knife surgery for central neurocytomas. J Neurosurg. 2012;117(Suppl):96\u2013101.","journal-title":"J Neurosurg"},{"issue":"1","key":"3665_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cncr.21109","volume":"104","author":"A Bertalanffy","year":"2005","unstructured":"Bertalanffy A, Roessler K, Koperek O, Gelpi E, Prayer D, Knosp E. Recurrent central neurocytomas. Cancer. 2005;104(1):135\u201342.","journal-title":"Cancer"},{"issue":"3","key":"3665_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1023\/A:1022553110232","volume":"61","author":"H Takao","year":"2003","unstructured":"Takao H, Nakagawa K, Ohtomo K. Central neurocytoma with craniospinal dissemination. J Neurooncol. 2003;61(3):255\u20139.","journal-title":"J Neurooncol"},{"issue":"5","key":"3665_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00005072-199705000-00011","volume":"56","author":"F Soylemezoglu","year":"1997","unstructured":"Soylemezoglu F, Scheithauer BW, Esteve J, Kleihues P. Atypical central neurocytoma. J Neuropathol Exp Neurol. 1997;56(5):551\u20136.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"3665_CR16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/00000478-200110000-00005","volume":"25","author":"DJ Brat","year":"2001","unstructured":"Brat DJ, Scheithauer BW, Eberhart CG, Burger PC. Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol. 2001;25(10):1252\u201360.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3665_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-006-9129-x","volume":"79","author":"Y Ogawa","year":"2006","unstructured":"Ogawa Y, Sugawara T, Seki H, Sakuma T. Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination. J Neurooncol. 2006;79(2):211\u20136.","journal-title":"J Neurooncol"},{"issue":"6","key":"3665_CR18","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1212\/01.WNL.0000115392.21898.E3","volume":"62","author":"D Rades","year":"2004","unstructured":"Rades D, Schild SE, Fehlauer F. Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology. 2004;62(6):987\u20139.","journal-title":"Neurology"},{"issue":"3","key":"3665_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/neuonc\/nov148","volume":"18","author":"V Dunet","year":"2016","unstructured":"Dunet V, Pomoni A, Hottinger A, Nicod-Lalonde M, Prior JO. Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis. Neuro Oncol. 2016;18(3):426\u201334.","journal-title":"Neuro Oncol"},{"issue":"10","key":"3665_CR20","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1007\/s00330-010-1819-2","volume":"20","author":"M Plotkin","year":"2010","unstructured":"Plotkin M, Blechschmidt C, Auf G, Nyuyki F, Geworski L, Denecke T, et\u00a0al. Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas. Eur Radiol. 2010;20(10):2496\u2013502.","journal-title":"Eur Radiol"},{"issue":"7","key":"3665_CR21","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/1097-0142(19951001)76:7<1224::AID-CNCR2820760720>3.0.CO;2-R","volume":"76","author":"K Mineura","year":"1995","unstructured":"Mineura K, Sasajima T, Itoh Y, Sasajima H, Kowada M, Tomura N, et\u00a0al. Blood flow and metabolism of central neurocytoma: a positron emission tomography study. Cancer. 1995;76(7):1224\u201332.","journal-title":"Cancer"},{"issue":"2","key":"3665_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF02988610","volume":"15","author":"T Ohtani","year":"2001","unstructured":"Ohtani T, Takahashi A, Honda F, Ishiuchi S, Kurihara H, Inoue T, et\u00a0al. Central neurocytoma with unusually intense FDG uptake: case report. Ann Nucl Med. 2001;15(2):161\u20135.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"3665_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0284185114521187","volume":"56","author":"R Sakamoto","year":"2015","unstructured":"Sakamoto R, Okada T, Kanagaki M, Yamamoto A, Fushimi Y, Kakigi T, et\u00a0al. Estimation of proliferative potentiality of central neurocytoma: correlational analysis of minimum ADC and maximum SUV with MIB-1 labeling index. Acta Radiol. 2015;56(1):114\u201320.","journal-title":"Acta Radiol"},{"issue":"7","key":"3665_CR24","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1606::AID-CNCR24>3.0.CO;2-B","volume":"85","author":"IR Mackenzie","year":"1999","unstructured":"Mackenzie IR. Central neurocytoma: histologic atypia, proliferation potential, and clinical outcome. Cancer. 1999;85(7):1606\u201310.","journal-title":"Cancer"},{"issue":"1","key":"3665_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jocn.2012.05.025","volume":"20","author":"G Kaur","year":"2013","unstructured":"Kaur G, Kane AJ, Sughrue ME, Oh M, Safaee M, Sun M, et\u00a0al. MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas. J Clin Neurosci. 2013;20(1):89\u201393.","journal-title":"J Clin Neurosci"},{"issue":"11","key":"3665_CR26","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s00701-016-2962-6","volume":"158","author":"C Tuleasca","year":"2016","unstructured":"Tuleasca C, Leroy HA, Regis J, Levivier M. Gamma Knife radiosurgery for cervical spine lesions: expanding the indications in the new era of Icon. Acta Neurochir. 2016;158(11):2235\u20136.","journal-title":"Acta Neurochir"},{"issue":"4","key":"3665_CR27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<790::AID-CNCR16>3.0.CO;2-V","volume":"79","author":"SE Schild","year":"1997","unstructured":"Schild SE, Scheithauer BW, Haddock MG, Schiff D, Burger PC, Wong WW, et\u00a0al. Central neurocytomas. Cancer. 1997;79(4):790\u20135.","journal-title":"Cancer"},{"issue":"4","key":"3665_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/jnnp.70.4.489","volume":"70","author":"A Bertalanffy","year":"2001","unstructured":"Bertalanffy A, Roessler K, Dietrich W, Aichholzer M, Prayer D, Ertl A, et\u00a0al. Gamma knife radiosurgery of recurrent central neurocytomas: a preliminary report. J Neurol Neurosurg Psychiatry. 2001;70(4):489\u201393.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3665_CR29","doi-asserted-by":"publisher","DOI":"10.3171\/2020.1.JNS191515","author":"YC Hung","year":"2020","unstructured":"Hung YC, Lee CC, Yang HC, Mohammed N, Kearns KN, Sun SB, et\u00a0al. Stereotactic radiosurgery for central neurocytomas: an international multicenter retrospective cohort study. J Neurosurg. 2020. https:\/\/doi.org\/10.3171\/2020.1.JNS191515.","journal-title":"J Neurosurg"},{"issue":"1","key":"3665_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.nec.2014.09.010","volume":"26","author":"DH Pan","year":"2015","unstructured":"Pan DH, Lee CC. The management of incidental central neurocytoma. Neurosurg Clin N Am. 2015;26(1):57\u201366.","journal-title":"Neurosurg Clin N Am"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03665-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T04:29:40Z","timestamp":1669609780000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03665-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3665"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03665-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"30 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"441"}}